Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Mitochondrial failure in sepsis; Acute mechnisms and long-term consequences. | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 0 | Mitrochondrial failure in Sepsis | |||
Drug development and new targets for redox disturbances in experimental vascular disease | Henning R.H., prof. dr. | Deelman L.E., dr. | Buikema J.H., dr. | Rijksuniversiteit Groningen (RUG) | 2022 | Drug development, redox disturbance, experimental vascular disease | ||
Learning in a student-run clinic: a new concept to improve medical education in pharmacotherapy | Schutte T., PhD | Agtmael M.A. van, prof. dr. | Richir M.C., MD PhD | Tichelaar J., dr. | Vrije Universiteit Amsterdam (VU) | 2018 | Pharmacotherapy education; Student-run clinic; Medical education; Workplace learning; Undergraduate education; | |
Rational prescribing in Europe: are future doctors well prepared? | Brinkman D.J., PhD | Agtmael M.A. van, prof. dr. | Richir M.C., MD PhD | Tichelaar J., dr. | Vrije Universiteit Amsterdam (VU) | 2018 | Clinical pharmacology; Pharmacotherapy; Prescribing; | |
Bioanalysis and biotransformation of tyrosine kinase inhibitors in oncology | Rood J.J.M., PhD | Beijnen J.H., prof. dr. | Sparidans R.W., dr. | Universiteit Utrecht (UU) | 2019 | |||
Towards better fall prevention - examining the interplay between factors that influence gait in older patients | Groot M.H. de, PhD | Beijnen J.H., prof. dr. | Lamoth C.J.C., dr. | Universiteit Utrecht (UU) | 2017 | Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients; | ||
Mounting an attack on the glioblastoma triad : proliferation, invasion and resistance | Gooijer M.C. de, PhD | Beijnen J.H., prof. dr. | Tellingen O. van, dr. | Universiteit Utrecht (UU) | 2019 | Glioblastoma; Blood-brain barrier; Therapy development; Pharmacology; Cell biology; Combination therapy; Mouse models; | ||
Unintended effects of anti-hyperglycaemic drugs studied in population-based cohorts | Driessen J.H.M., PhD | Bergh J.P.W. van den, prof. dr. | Vries F. de, prof. dr. | Onzenoort H.A.W. van, PhD | Universiteit Maastricht (UM) | 2017 | Hyperglycaemic drugs; Population-based; | |
Methodological approaches to the pharmacogenomics of statins | Peters B.J.M., dr. | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Klungel O.H., prof. dr. | Universiteit Utrecht (UU) | 2010 | Methodology; Statins; Pharmacogenomics; | |
Challenges in the clinical development of orphan drugs | Kreeftmeijer-Vegter A.R., PhD | Boer A. de, prof. dr. | Vries P.J. de, dr. | Universiteit Utrecht (UU) | 2015 | Orphan drugs; Clinical development; Paediatric formulation; Pharmacokinetics; Efficacy; Safety; Regulatory; | ||
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergy | Ahmadizar F., PhD | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2016 | Children; Diabetes mellitus; Allergy | ||
Assessing the impact of gout:validating and understanding outcomes | Spaetgens B.P.A., dr | Boonen A.E.R.C.H., prof. dr. | Vries F. de, prof. dr. | Universiteit Maastricht (UM) | 2017 | |||
Supporting patients : pharmacy based interventions to improve medication adherence | Kooij M.J., PhD | Bouvy M.L., prof. dr. | Heerdink E.R., dr. | Dijk C.E.M.J. van, dr. ir. | Universiteit Utrecht (UU) | 2015 | Medication adherence; Pharmacists; Intervention; Pharmacy; Compliance; Community pharmacy; | |
Readmission to primary care : the role of community pharmacists post-discharge | Ensing H.T., PhD | Bouvy M.L., prof. dr. | Koster E.S., PhD | Dooren A.A. van, dr. | Universiteit Utrecht (UU) | 2017 | Safety; Care continuity; Discharge; Pharmacist home visit; | |
Clinical pharmacological studies in tuberculosis patients | Semvua H.H., PhD | Burger D.M., prof. dr. | Aarnoutse R.E., dr. | Boeree M.J., dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; Pharmacokinetics; Tuberculosis | |
Optmizing long-term care for hiv-infected patients in Thailand | Ramautarsing R.A., PhD | Burger D.M., prof. dr. | Wit F.W.N.M., dr. | Wijgert J.H.H.M. van de, dr. | Universiteit van Amsterdam (UvA) | 2013 | HIV; clinical pharmacology | |
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little | Colbers E.P.H., PhD | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2015 | HIV; antiretroviral agents; clinical pharmacology; drug drug interactions | |||
Making things easier: how to improve antiviral drug treatment for children | Bastiaans D.E.T., dr. | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2016 | Clinical pharmacology; Antiviral drug treatment; | |||
Early phase clinical drug development for HPV-induced disorders: novel tools and treatments | Rijsbergen M. | Burggraaf J., prof. dr. | Rissmann R, prof.dr. | Poelgeest M.I.E. van, dr. | Universiteit Leiden (UL) | 2020 | HPV-induced diseases; | |
Investigations of skin inflammation with a novel dermatology toolbox for early phase clinical drug development | Kolk T. van der, dr | Burggraaf J., prof. dr. | Rissmann R, prof.dr. | Universiteit Leiden (UL) | 2021 | Skin inflammation Dermatology toolbox Early phase clinical drug development Trial at home Inflammation models Skin microbiome Atopic dermatitis | ||
Rational use of antibiotics | Dijkmans A.C. | Burggraaf J., prof. dr. | Universiteit Leiden (UL) | 2020 | Antibiotics; Pharmacokinetics;Flucloxacillin;Penicillin; Pheneticillin;Rifampin;Colistin;Fosfomycin | |||
Characterization and re-evaluation of experimental pain models in healthy subjects | Siebenga P.S | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2020 | Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala | |||
Measuring pharmacodynamics in early clinical drug studies in multiple sclerosis | Kanhai K.M.S | Cohen A.F., prof. dr. | Groeneveld G.J., prof. dr. | Universiteit Leiden (UL) | 2019 | Multiple sclerosis Drug development Biomarkers Remyelination | ||
The Clinical Pharmacology of performance enhancement and doping detection in sports | Heuberger J., dr. | Cohen A.F., prof. dr. | Groeneveld G.J., prof. dr. | Rotmans J.I., dr. | Universiteit Leiden (UL) | 2019 | Performance enhancement and doping detection in sports | |
Optimisation of first clinical studies in special populations: towards semi-physiological pharmacokinetics | Strougo A., PhD | Danhof M., prof. dr. | Freijer J., dr. | Yassen A., dr. | Universiteit Leiden (UL) | 2015 | Special-population; Model-based; PK-model; Paediatrics; Children; Hepatic and renal impairment; Semi-physiological; Population approach; PBPK; | |
Adherence to antiretroviral combination therapy in children : what a difference half a day makes... | Piana C., PhD | Danhof M., prof. dr. | Della Pasqua O.E., dr. | Universiteit Leiden (UL) | 2013 | Paediatrics; Antiretroviral combination therapy; Compliance; Antiretroviral drugs; Paediatric populations; Drug combinations; Model-based; Covariate analysis; Predictive pharmacokinetic models; Clinical trial simulations; Adherence; Forgiveness of non-adherence; | ||
Pharmacokinetics, pharmacodynamics and safety of different propofol formulations | Knibbe C.A.J., prof. dr. | Danhof M., prof. dr. | Aarts L.P.H.J., prof. dr. | Kuks P.F.M., dr. | Universiteit Leiden (UL) | 2002 | Pharmacokinetics; Pharmacodynamics; Propofol; | |
From data to models : reducing uncertainty in benefit risk assessment : application to chronic iron overload in children | Bellanti F., PhD | Danhof M., prof. dr. | Della Pasqua O.E., dr. | Universiteit Leiden (UL) | 2015 | Benefit-risk assessment; Paediatrics; Iron chelations; PK-PD modelling; Modelling-&-simulations; Multi-criteria-decision-analysis; Iron-overload; Deferiprone; Deferoxamine; | ||
Novel directions in therapy against age-related vascular disease | Wu H., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Cardiovascular disease; | ||
Preeclampsia, the renin-angiotensin-aldosterone system and beyond | Verdonk K., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system; | |||
New therapeutic targets in cardiovascular disease: focus on the renin-angiotensin system and lipid metabolism | Sun Y | Danser A.H.J., prof. dr. | Lu X., PhD | Erasmus Universiteit Rotterdam (EUR) | 2020 | Renin-angiotensin system; lipid metabolism; Vascular reactivity; Pharmacology; Treatment options; | ||
The alternative renin-angiotensin system: exploration of its therapeutic potential | Sevá Pessôa B., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | ||
Natriuretic peptides, diagnostics and prognostic biomarkers | Rutte J.H.W., dr. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2010 | Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system; | ||
Vascular Effects of Current and Novel Antimigraine Drugs | Rubio Beltrán AE | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Migraine; Vascular reactivity; Drug efficacy; Pharmacology; | ||
Aortic pathology and the role of the renin-angiotensin system | Molzer E., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | |||
The (pro)renin receptor: moving away from prorenin? | Lu X., PhD | Danser A.H.J., prof. dr. | Meima M.E., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Cardiovascular disease; Pharmacology; Prorenin; | ||
Hypertension and renal toxicity during angiogenesis inhibition: Salt dependency and treatment options | Lankhorst S. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Kappers M.H.W., PhD | Erasmus Universiteit Rotterdam (EUR) | 2016 | Hypertension; Renal function; Treatment options | |
Neurovascular pharmacology of migraine: epigenetics and sex hormones | Labruijere S., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology; | ||
Peripheral Projections of the Trigeminovascular System as Antimigraine Target | Labastida Ramírez A | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Migraine; Vascular reactivity; Pharmacology; | ||
(Pro)renin revisited: new insights from studies in mast cells | Krop M., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2009 | Cardiovascular disease; Pharmacology; Prorenin; | |||
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach | Kappers M.H.W., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Cancer; Pharmacology; Antihypertensive drugs; | |||
The role of aldosterone and aldosterone blockade in hypertension | Jansen P.M., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2013 | Cardiovascular disease; Antihypertensive drugs; Pharmacology; | |||
Microvasculature, the Trigeminal System and Migraine: A focus on female sex hormones | Ibrahimi K., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Migraine; Microvasculature; Trigeminal System; Female Sex Hormones | |
The more complex renin-angiotensin system: new insights into an old system | Gembardt F., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Renin-angiotensin system; | |||
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition | Esch J.H.M. van, dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2008 | Cardiovascular disease; Pharmacology; Renin-angiotensin system; | |||
Vascular aging from DNA damage to protection | Ďurik M., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Cardiovascular disease; Pharmacology; | ||
Neurovascular pharmacology of prospective antimigraine drugs | Chan K.Y., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Migraine; Neurovascular pharmacology; | ||
Cardiac aldosterone: origin and effects | Chai W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors | Batenburg W.W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Determinants of treatment outcomes in epilepsy | Wassenaar M., PhD | Egberts A.C.G., prof. dr. | Leijten F.S.S., dr. | Uijl S.G., dr. | Universiteit Utrecht (UU) | 2014 | Epilepsy; Treatment; Treatment outcomes; Quality of life; Patient-perspectives; Clinical determinants; Seizures; Pharmacology; Daily practice; Community-based; |
Go to page:
- of 6
- >